121 related articles for article (PubMed ID: 7709304)
1. Corticosteroid therapy and bone mass--comparison of rheumatoid arthritis and systemic lupus erythematosus.
Kalla AA; Meyers OL; Kotze TJ; Laubscher R
S Afr Med J; 1994 Jul; 84(7):404-9. PubMed ID: 7709304
[TBL] [Abstract][Full Text] [Related]
2. Influences on bone mineral density in Malaysian premenopausal systemic lupus erythematosus patients on corticosteroids.
Yeap SS; Fauzi AR; Kong NC; Halim AG; Soehardy Z; Rahimah S; Chow SK; Goh EM
Lupus; 2009 Feb; 18(2):178-81. PubMed ID: 19151123
[TBL] [Abstract][Full Text] [Related]
3. A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus.
Yeap SS; Fauzi AR; Kong NC; Halim AG; Soehardy Z; Rahimah I; Chow SK; Goh EM
J Rheumatol; 2008 Dec; 35(12):2344-7. PubMed ID: 19004038
[TBL] [Abstract][Full Text] [Related]
4. Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss.
Adachi J; Cranney A; Goldsmith CH; Bensen WG; Bianchi F; Cividino A; Craig GL; Kaminska E; Sebaldt RJ; Papaioannou A
J Rheumatol; 1994 Oct; 21(10):1922-6. PubMed ID: 7837160
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
Compeyrot-Lacassagne S; Tyrrell PN; Atenafu E; Doria AS; Stephens D; Gilday D; Silverman ED
Arthritis Rheum; 2007 Jun; 56(6):1966-73. PubMed ID: 17530722
[TBL] [Abstract][Full Text] [Related]
6. Cortisol catabolism by lymphocytes of patients with systemic lupus erythematosus and rheumatoid arthritis.
Klein A; Buskila D; Gladman D; Bruser B; Malkin A
J Rheumatol; 1990 Jan; 17(1):30-3. PubMed ID: 2313669
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density in premenopausal women with systemic lupus erythematosus.
Uaratanawong S; Deesomchoke U; Lertmaharit S; Uaratanawong S
J Rheumatol; 2003 Nov; 30(11):2365-8. PubMed ID: 14677178
[TBL] [Abstract][Full Text] [Related]
8. Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving corticosteroids.
Lee C; Almagor O; Dunlop DD; Manzi S; Spies S; Chadha AB; Ramsey-Goldman R
Rheumatology (Oxford); 2006 Jan; 45(1):53-60. PubMed ID: 16278288
[TBL] [Abstract][Full Text] [Related]
9. Ten-year absolute fracture risk and hip bone strength in Canadian women with systemic lupus erythematosus.
Lee JJ; Aghdassi E; Cheung AM; Morrison S; Cymet A; Peeva V; Neville C; Hewitt S; DaCosta D; Pineau C; Pope J; Fortin PR
J Rheumatol; 2012 Jul; 39(7):1378-84. PubMed ID: 22660811
[TBL] [Abstract][Full Text] [Related]
10. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
Hepburn AL; Mason JC; Davies KA
Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
[TBL] [Abstract][Full Text] [Related]
11. Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study.
Lambrinoudaki I; Chan DT; Lau CS; Wong RW; Yeung SS; Kung AW
J Rheumatol; 2000 Jul; 27(7):1759-65. PubMed ID: 10914864
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral density changes in women with systemic lupus erythematosus.
Boyanov M; Robeva R; Popivanov P
Clin Rheumatol; 2003 Oct; 22(4-5):318-23. PubMed ID: 14579164
[TBL] [Abstract][Full Text] [Related]
13. Loss of bone mineral density in Chinese pre-menopausal women with systemic lupus erythematosus treated with corticosteroids.
Li EK; Tam LS; Young RP; Ko GT; Li M; Lau EM
Br J Rheumatol; 1998 Apr; 37(4):405-10. PubMed ID: 9619891
[TBL] [Abstract][Full Text] [Related]
14. Osteopenia in patients with glomerular diseases requiring long-term corticosteroid therapy.
de Deus RB; Ferreira AC; Kirsztajn GM; Heilberg IP
Nephron Clin Pract; 2003; 94(3):c69-74. PubMed ID: 12902633
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroids and low bone mineral density affect hip cartilage in systemic lupus erythematosus patients: Quantitative T2 mapping.
Hagiwara S; Nakamura J; Watanabe A; Kishida S; Ohtori S; Omae T; Miyamoto S; Orita S; Takahashi K
J Magn Reson Imaging; 2015 Dec; 42(6):1524-31. PubMed ID: 26019059
[TBL] [Abstract][Full Text] [Related]
16. A comparison of rheumatoid arthritis and systemic lupus erythematosus trial design: a commentary on ways to improve the number of positive trials in SLE.
Miles A; Pope JE
Clin Exp Rheumatol; 2015; 33(5):671-80. PubMed ID: 26315693
[TBL] [Abstract][Full Text] [Related]
17. Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems.
Härle P; Straub RH; Wiest R; Mayer A; Schölmerich J; Atzeni F; Carrabba M; Cutolo M; Sarzi-Puttini P
Ann Rheum Dis; 2006 Jan; 65(1):51-6. PubMed ID: 15941834
[TBL] [Abstract][Full Text] [Related]
18. Effects of nutritional supplementation on bone mineral status of children with rheumatic diseases receiving corticosteroid therapy.
Warady BD; Lindsley CB; Robinson FG; Lukert BP
J Rheumatol; 1994 Mar; 21(3):530-5. PubMed ID: 8006898
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of pregnenolone and 17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: relation to other adrenal hormones.
Vogl D; Falk W; Dorner M; Schölmerich J; Straub RH
J Rheumatol; 2003 Feb; 30(2):269-75. PubMed ID: 12563679
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy.
Cortet B; Flipo RM; Blanckaert F; Duquesnoy B; Marchandise X; Delcambre B
Rev Rhum Engl Ed; 1997; 64(7-9):451-8. PubMed ID: 9338926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
